⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MAIA News
MAIA Biotechnology, Inc.
$207B Market Shift: The Race for Fast Track Approval in Oncology
prnewswire.com
AVBP
ONCY
RLAY
ZLAB
MAIA
Late-Stage Breakthroughs: How 2026's Top Clinical Platforms Are Redefining Cancer Treatment
prnewswire.com
ACRV
BNTX
IBRX
ONCY
MAIA
MAIA Biotechnology Advances Ateganosine Cancer Treatment Program, Outlines Targeted 2026 Clinical Milestones and Growth Momentum
globenewswire.com
MAIA
Diamond Equity Research Releases Update Note on MAIA Biotechnology, Inc. (NYSE: MAIA)
globenewswire.com
MAIA
MAIA Biotechnology Board Members Continue to Participate in Private Placement Financings
globenewswire.com
MAIA
MAIA Biotechnology Announces $1.51 Million Private Placement
globenewswire.com
MAIA
MAIA’s Ateganosine Surges Ahead with Breakthrough Momentum as Pivotal Phase 3 Trial Initiates
globenewswire.com
MAIA
MAIA Biotechnology Announces First Patient Dosed in THIO-104 Phase 3 Pivotal Trial Evaluating Ateganosine as Third-Line Treatment for Advanced Non-Small Cell Lung Cancer
globenewswire.com
MAIA
MAIA Leadership Continues Insider Buying in 2025 and Trial Data Signals Breakout Potential
globenewswire.com
MAIA
MAIA Takes Aim at a $50B Immunotherapy Market with Breakthrough Telomere-Targeting Approach
globenewswire.com
MAIA
MRK